Cell-specific effects of Nox2 on the acute and chronic response to myocardial infarction

Area of Science:

• Cardiovascular Biology
• Oxidative Stress Research
• Myocardial Infarction Pathophysiology

Background:

• Increased reactive oxygen species (ROS) contribute to adverse cardiac remodeling and heart failure post-myocardial infarction (MI).
• NADPH oxidase-2 (Nox2) is a key cardiac ROS source, upregulated after MI, and its genetic deletion shows protective effects.
• The specific cell type (cardiomyocyte vs. endothelial cell) mediating Nox2's detrimental role in post-MI remodeling remains unclear.

Purpose of the Study:

• To investigate the cell-specific roles of NADPH oxidase-2 (Nox2) in cardiac remodeling following myocardial infarction (MI).
• To compare the impact of Nox2 overexpression in cardiomyocytes versus endothelial cells on post-MI cardiac function and structure.

Main Methods:

• Generation of transgenic mouse models with targeted Nox2 overexpression in cardiomyocytes (cardio-Nox2TG) and endothelial cells (endo-Nox2TG).
• Induction of permanent myocardial infarction (MI) via left coronary artery ligation in transgenic mice and wild-type littermates (WT).
• Assessment of infarct size (MRI), cardiac dysfunction, cardiomyocyte hypertrophy, interstitial fibrosis, and survival up to 4 weeks post-MI.

Main Results:

• Initial infarct size and cardiac dysfunction were comparable across all groups post-MI.
• Cardiomyocyte hypertrophy and interstitial fibrosis were significantly increased in cardio-Nox2TG mice compared to WT after MI.
• Post-MI survival tended to be worse in cardio-Nox2TG mice, while endo-Nox2TG mice showed no significant differences compared to WT.

Conclusions:

• Cardiomyocyte-specific Nox2 activity plays a more critical role in adverse cardiac remodeling after myocardial infarction than endothelial cell Nox2.
• Targeting Nox2 within cardiomyocytes may be a more effective strategy for mitigating post-MI cardiac remodeling.